{
  "pmcid": "12482957",
  "sha256": "82977727b0170f7aa473b170d7bd0aecb4e3542d0b5d6c1dd58c6400b88b1dff",
  "timestamp_utc": "2025-11-09T22:29:03.031652+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.874819401444789,
    "reading_ease": 14.710634674922602,
    "word_count": 204
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Liposomal Bupivacaine in Quadratus Lumborum Block for Laparoscopic Nephrectomy"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "single-center, triple-blind, randomised controlled trial"
      },
      "Participants": {
        "score": 2,
        "evidence": "116 patients aged 20â€“75 years undergoing elective laparoscopic nephrectomy were enrolled at Xuzhou Medical University"
      },
      "Intervention": {
        "score": 2,
        "evidence": "10 mL of liposomal bupivacaine (133 mg) with 10 mL saline or 20 mL of 0.375% bupivacaine hydrochloride"
      },
      "Objective": {
        "score": 1,
        "evidence": "This trial compared the analgesic efficacy of liposomal bupivacaine versus bupivacaine hydrochloride in QLB-LSAL."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was total morphine equivalent consumption within 48 hours postoperatively."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, with allocation concealed in opaque envelopes."
      },
      "Blinding": {
        "score": 3,
        "evidence": "Patients, surgeons, and outcome assessors were blinded."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "Between January and May 2025, 116 patients were randomised: 58 to each group."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis was intention-to-treat."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The liposomal bupivacaine group had significantly lower morphine consumption (mean difference = 11.1 mg, 95% CI 10.1 to 12.1, P < 0.001)"
      },
      "Harms": {
        "score": 1,
        "evidence": "No significant difference in adverse events was observed between groups."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: ChiCTR2400094955."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 23,
    "max_score": 25
  }
}